F—D—C REPORTS —-
`FOUNDED 1339
`$1,045 A YEAR
`
`“The Pink Shee‘ti’.
`
`PRESCRIPTION PHARMACEUTICALS AND BIOTECHNOLOGY
`
`Vol. 61, No. 46 November 15, 1999
`THE NEWS THIS WEEK
`
`.
`
`Fuilsawa will fund Medicine Shoppe disease management pilot in transplant patients using Health Hero Network’s?
`Internet communication system. HHN is finalizing deal with another firm in pharmacy industry for use of its
`technology, which has been launched in managed care arena ............................................................................................ 25
`
`Fuiisawa To Fund Medicine Shoppe Transplant Management Program
`The Medicine Shoppe and Fujisawa will partner to
`conduct a disease management program for transplant
`patients using Health Hero Network’s intemet
`communication system.
`
`The HHN online system can also be used by pharmacists
`to monitor patients after dispensing medications,
`Medicine Shoppe Exec VP— Marketing Gary Levine
`pointed out at a Nov. 9 Congressional briefing on the role
`of technology in medication practices.
`
`The pharmacy company will meet with a St. Louis-area
`hospital shortly to discuss implementing the pilot
`program in conjunction with the hospital’s transplant
`surgery department. Funding for the pilot program will
`be provided by Fujisawa, which markets the anti-organ
`rejection drug Prograf (tacrolimus).
`
`The Medicine Shoppe hopes to initiate another HHN
`pilOt program with the medical center, targeted at
`patients on lipid lowering agents. The
`" M ‘
`pharmacy firm also has met with health
`systems to discuss HHN programs in
`congestive heart failure. It expects to
`work directly with physicians and health
`systems in implementing the pilots.
`
`
`
`The briefing was sponsored by the National
`Association of Chain Drugs Stores and co~sponsored
`by the National Consumers League, the National
`Council on Aging, Sens. Bennett (R-Utah) and Dodd
`(D—Conn.), and Reps. Greenwood (R-Penn.) and
`Dooley (])-Calif.). The presentation focused on the
`
`pharmacist’s role in disease management and the
`importance of allowing health providers, such as
`pharmacistsnc access patient’s health information.
`
`HHS issued draft regulations on medical records
`privacy Oct. 29 that would limit access to electronic
`records (“The Pink Sheet” Nov. 1. p. 8).
`
`’ HHN’s Health Buddy device and the
`Health Hero Network online service allow physicians
`and pharmacists to monitor chronically ill patients, and
`provide instructions, reminders and other information
`to patients at home.
`
`Patients can view the information and respond through
`the Health Buddy appliance, a small desktop device
`that connects with the HHN online service via a
`
`telephone connection.
`
`Patients logging on to the HHN online service see
`customized content posted for them by their health care
`provider, and may be asked specific questions about
`their health or asked to answer “quiz” questions meant
`to educate the patient on his or her condition and
`warning signs to watch for. All questions are in
`multiple choice format, and patients press one of four
`buttons on the appliance to respond.
`
`Levine described technologies that pharmacists use to
`provide disease management services. The HHN online
`system can track multiple prescriptions, minimize
`adverse reactions, monitor patient compliance and
`manage dose titration when necessary.
`
`The system can also ask patients if they need
`a prescription refilled, and arrange for pick-up
`at the participating pharmacy.
`
`Mountain View, Calif.-based HHN plans to
`launch its Direct Connect Service, which will
`allow patients to send glucose, peak flow,
`blood pressure or weight readings directly to the
`physician or pharmacist, in late 1999.0r early 2000.
`
`The company has filed a 510(k) application with FDA
`for clearance to connect the Health Buddy appliance to
`
`1
`
`Bosch Ex. 2014
`Bosch EX. 2014
`Cardiocom v. Bosch IPR2013-00468
`Cardiocom V. Bosch IPR2013—00468
`
`

`

`blood glucose meters, and will follow with applications
`for connections with additional home devices.
`
`HHN is completing an agreement with another firm in
`the phannacy/pharmacy benefit management field.
`
`To date, the HHN online service has been launched in
`
`the managed care arena, with ongoing disease manage-
`ment programs in CHF (Empire Blue Cross Blue
`Shield); CHF and asthma (Telesis Medical Manage-
`ment); CHF and diabetes (Santa Clara County Indiv-
`idual Practice Association); and CHF and senior well
`being (Bridgeport Hospital and United Home Care).
`
`Most HHN disease management programs begin as
`pilots with 50 to 100 patients, and are expanded to
`approximately 1,000 to 2,000 patients.
`
`Three clinical trials using Health Buddy are underway
`in a variety of conditions: depression, bi-polar disorder
`and obsessive compulsive disorder (Stanford Uni-
`versity); CHF and coronary artery bypass graft surgery
`(University of Nebraska); and juvenile asthma
`(University of California at Berkeley and Children’s
`Hospital, Oakland). 6 O
`
`2
`
`